F-group (family)
4.1.1.34 MBT
Ligands and drugs
362
Member domains
107
with ligand contacts (≤ 4 Å)
29.6% of members
95
with DrugDomain annotations
26.2% of members
60
with a DrugBank compound
16.6% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 4.1.1.34 belongs to X-group 4 SH3, which binds 8.3 ligand superclasses per 20 proteins, broader than 62% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB01714 | MLZ | Epsilon-N-methyllysine | 6 |
| DB03345 | — | Mercaptoethanol | 2 |
| DB03362 | MLY | N-Dimethyl-Lysine | 2 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| UNX | UNKNOWN ATOM OR ION | 20 |
| IOD | IODIDE ION | 6 |
| MLZ | N-METHYL-LYSINE | 6 |
| UWN | [2-(phenylamino)benzene-1,4-diyl]bis{[4-(pyrrolidin-1-yl)piperidin-1-yl]methanone} | 5 |
| CL | CHLORIDE ION | 4 |
| E3X | 4-(1-methyl-3,6-dihydro-2H-pyridin-4-yl)phenol | 4 |
| NAmetal | SODIUM ION | 4 |
| COmetal | COBALT (II) ION | 3 |
| MLY | N-DIMETHYL-LYSINE | 3 |
| P8H | 3-bromo-5-[(4-pyrrolidin-1-ylpiperidin-1-yl)carbonyl]pyridine | 2 |
| 1VZ | 4-(pyrrolidin-1-yl)-1-{4-[2-(pyrrolidin-1-yl)ethyl]phenyl}piperidine | 1 |
| EC7 | (S)-N-(cyclopropylmethyl)-N~2~-methyl-N-[2-methyl-2-(1-methylpiperidin-4-yl)propyl]alaninamide | 1 |